Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-08-26

Clinical Trial Update: Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab after combination chemotherapy and trastuzumab in patients undergoing surgery for stage II/III breast cancer; current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HERCEPTIN (trastuzumab)

Snippet

Sponsor: Instituto Nacional de Cancerologia, Columbia | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN